Dr. John E. Doster
Claim this profileAnMed Health Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
18 reported clinical trials
33 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
Stage II
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials John E. Doster is currently running
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
More about John E. Doster
Clinical Trial Related1 year of experience running clinical trials · Led 18 trials as a Principal Investigator · 12 Active Clinical TrialsTreatments John E. Doster has experience with
- Biospecimen Collection
- Gemcitabine Hydrochloride
- Atezolizumab
- Oxaliplatin
- Chemotherapy
- Pembrolizumab
Breakdown of trials John E. Doster has run
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John E. Doster specialize in?
John E. Doster focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is John E. Doster currently recruiting for clinical trials?
Yes, John E. Doster is currently recruiting for 11 clinical trials in Anderson South Carolina. If you're interested in participating, you should apply.
Are there any treatments that John E. Doster has studied deeply?
Yes, John E. Doster has studied treatments such as Biospecimen Collection, Gemcitabine Hydrochloride, Atezolizumab.
What is the best way to schedule an appointment with John E. Doster?
Apply for one of the trials that John E. Doster is conducting.
What is the office address of John E. Doster?
The office of John E. Doster is located at: AnMed Health Cancer Center, Anderson, South Carolina 29621 United States. This is the address for their practice at the AnMed Health Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.